跳至主要内容
临床试验/EUCTR2007-000759-32-IT
EUCTR2007-000759-32-IT进行中(未招募)不适用

Evaluation of the efficacy of green tea catechins (Categ Plus) in the chemoprevention of prostatic carcinoma in patients with high grade PIN. A randomised multicentric, double blind clinical study. - ND

SOFAR SPA0 个研究点开始时间: 2007年7月3日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
SOFAR SPA

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • 1. age > 45 years
  • 2. patients with High grade PIN diagnosed by biopsy. it is possible to refer to a previous biopsy (not before 6 months)
  • 3. no clinic evidence of prostate cancer
  • 4.written consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. patients taking 5-alfa reduttase drugd (finasteride, dutasteride)
  • 2. patients with other malignances
  • 3. diseases of kidney and liver, cardiovascular and haematological disease, pulmonary or neurological, gastroenterologic or endocrine diseases

研究者

发起方
SOFAR SPA

相似试验